Search Results - "Lapic, I"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
  2. 2

    Changes in salivary oxidative status, salivary cortisol, and clinical symptoms in female patients with temporomandibular disorders during occlusal splint therapy: a 3-month follow up by Vrbanović, E, Lapić, I, Rogić, D, Alajbeg, I Z

    Published in BMC oral health (06-06-2019)
    “…Differences in the expression of oxidative stress (OS) markers between female patients with temporomandibular disorders (TMD) and healthy individuals indicate…”
    Get full text
    Journal Article
  3. 3

    Influence of saliva on the results of global laboratory coagulation tests by Špiljak, B, Šimunović, L, Lapić, I, Rogić, D, Špalj, S, Vuletić, L

    Published in Australian dental journal (01-09-2020)
    “…Background Oral wounds inevitably come into contact with saliva which can affect the time needed for bleeding to stop. The influence of saliva can be…”
    Get full text
    Journal Article
  4. 4

    Int J Med Inform.: Changing the electronic request form proves to be an effective tool for optimizing laboratory test utilization in the emergency department by Lapic, I, Juros, G.F, Rako, I, Rogic, D

    Published in Croatian medical journal (01-06-2017)
    “…OBJECTIVES: Appropriate laboratory utilization more often than not needs to be initiated by the laboratory. This study was performed to analyze the impact on…”
    Get full text
    Journal Article
  5. 5

    A-079 Analytical Assessment of Abbott’s SigmaSTRONG assays on the Alinity c and ARCHITECT c Systems by Cox, S, James, T, Allott, K, Ervankai, R, Potter, G H, Allen, G, Lapić, I, Komljenović, S, Bogić, A, Rogić, D

    Published in Clinical chemistry (Baltimore, Md.) (27-09-2023)
    “…Abstract Introduction Clinical chemistry assays are responsible for 57% of all core lab testing (1) as a result there is an ever-increasing demand to improve…”
    Get full text
    Journal Article
  6. 6

    PB2204 SERUM YKL‐40 LEVELS ARE ELEVATED IN PRIMARY AND SECONDARY MYELOFIBROSIS AND MAY BE AFFECTING THEIR SURVIVAL by Krečak, I., Gverić‐Krečak, V., Rončević, P., Lapić, I., Fumic, K., Bašić‐Kinda, S., Duraković, N.

    Published in HemaSphere (01-06-2019)
    “…Background: Primary and secondary myelofibrosis (PMF and SMF) are clonal hematopoietic stem cell disorders characterized by myeloproliferation, bone marrow…”
    Get full text
    Journal Article